Jilted Ranbaxy Sues Barr, Teva Over Allegra Generic

Law360, New York (October 11, 2005, 12:00 AM EDT) -- Three of the world’s largest generic drug makers are set to duke it out in court over a deal gone sour for the unusually risky launch of a copycat version of Sanofi-Aventis's blockbuster allergy medicine Allegra.

India’s Ranbaxy Laboratories Ltd. and Agvar Chemicals, a distributor, said Monday they had filed a joint complaint against Barr Pharmaceuticals and Israel’s Teva Pharmaceuticals in New Jersey Superior Court.

Ranbaxy’s lawsuit is seeking damages and equitable relief for “breach of contract, fraud and tortious interference” over a supply agreement for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.